John Hoekman

Insider Reports History

Entity
Individual
Location
C/O Impel Neuropharma, Inc., 201 Elliott Ave. W, St. 260, Seattle, WA
Signature
/s/ John Leaman, M.D. as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Hoekman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
IMPEL PHARMACEUTICALS INC Chief Scientific Officer Stock Option (right to buy) 42.5K Feb 14, 2023 Direct

Insider Reports Filed by John Hoekman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IMPL IMPEL PHARMACEUTICALS INC Feb 14, 2023 1 $0 4 Feb 16, 2023 Chief Scientific Officer
IMPL IMPEL NEUROPHARMA INC Jan 26, 2022 1 $0 4 Jan 28, 2022 Chief Scientific Officer
IMPL IMPEL NEUROPHARMA INC Dec 22, 2021 2 $32.8K 4 Dec 23, 2021 Chief Scientific Officer
IMPL IMPEL NEUROPHARMA INC Jul 20, 2021 1 $0 4 Jul 26, 2021 Chief Scientific Officer
IMPL IMPEL NEUROPHARMA INC Apr 27, 2021 2 $0 4/A Jun 7, 2021 Chief Scientific Officer